{'fraction_non_alphanumeric': 0.03743961352657005, 'fraction_numerical': 0.03260869565217391, 'mean_word_length': 5.426356589147287, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Evaluation of effectiveness of treatment of cochleovestibular disorders with mildronate].

The results of mildronate treatment of 67 patients with acute (23 patients) and chronic (44 patients) cochleovestibular disorders of different origin are discussed. The efficacy was evaluated in terms of subjective reports and objective parameters. The therapy proved effective in 53 (79.1%) patients, out of which it was good in 30 (44.8%) patients and satisfactory in 23 (34.3%) patients. The therapeutic results were better in patients with acute cochleovestibular dysfunction: good results were seen in 86.9% patients. In patients with chronic cochleovestibular dysfunction good results were recorded only in 75.0% patients. It is concluded that mildronate can be effectively used to treat patients with cochleovestibular disorders.